Targeting p19 as a treatment option for psoriasis: an evidence-based review of guselkumab
Todd Wechter,1 Abigail Cline,2 Steven R Feldman2–4 1Stony Brook Medicine, Stony Brook, NY, USA; 2Center for Dermatology Research, Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, NC, USA; 3Department of Pathology, Wake Forest School of Medicine, Winston-Salem, NC, USA; 4Department of Public Health Sciences, Wake Fores